Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug

Strides Pharma Science rallied 3.13% to Rs 1,395.80 after the company's step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore has received US Food & Drug Administration (USFDA) approval for Fluoxetine tablets.

By: business-standard.com

Sep 16 2024
0
0 Views

Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug

Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug

Related

Dixon Tech hits record high as arm inks MoU with Asus India

Sensex, Nifty end with minor gains; media shares outperform

Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug

INR appreciates under 83.90 per US dollar mark

Nifty September futures trade at premium

Godrej Consumer MD and CEO Sudhir Sitapati throws weight behind Dhaval Buch

Northern Arc Capital IPO subscribed 2.86 times

Volumes jump at Triveni Engineering and Industries Ltd counter

Lumax Auto Tech jumps after inking pact to acquire GreenFuel Energy

Veeram Securities Ltd leads losers in 'B' group

Major Asian markets closed for holidays, China economic data disappoints

Australian markets hit record high

Dixon Tech hits record high as arm inks MoU with Asus India